We are thrilled to announce the exciting collaboration between Knight Cancer Center and the Knight Cancer Research Institute, focusing on the groundbreaking elio plasma focus Liquid Biopsy Panel for solid tumors. KDL will be the first institute in the Pacific Northwest to launch this innovative technology, and we are eager to bring our product experts to meet with your team and discuss the potential impact this collaboration will have on cancer research and treatment.
We look forward to connecting with you soon and exploring how this partnership can pave the way for new advancements in oncology!
Agenda:
11:00 am - Seminar Presentation in the KCRB Auditorium featuring
- Kenneth Valkenburg, PhD Director of Research & Development
- Jennifer Jacksin, PhD Director of Translational Strategy, R&D
12:00pm - Lunch to be provided and time to connect with your KDL & PGDx team members & leaders.
